RGS6 and heart failure: Thus, decreasing RGS6 expression in the murine myocardium provides marked protection against chemotherapy-dependent myocyte loss, actions that would be expected to help maintain cardiac output and prevent heart failure in patients undergoing chemotherapy particularly those at high risk for adverse cardiac events.